Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy

  • End date
    Dec 31, 2024
  • participants needed
  • sponsor
    University of Aarhus
Updated on 4 April 2021
vitamin d
treatment regimen
active vitamin d
minimal change disease


Traditionally MCN is treated with a high dose of prednisolone, which induces remission in 60-90% of patients. Prednisolone treatment contains numerous side effects and the current dose is empiric. Given the lack of efficacy evidence and the risk associated with the currently accepted treatment regimen there is a need to characterize the outcome in MCN further, and to establish new, and potentially less toxic treatment regimens.

The aim is to examine if treatment with reduced dose of prednisolone in combination with activated vitamin D is as effective as standard high dose prednisolone in achieving remission and preventing relapse in MCN, and if reduced dose prednisolone is associated with fewer side effects compared to standard dose. Furthermore, the study will examine the influence of prednisolone metabolism on the efficacy and side effects of prednisolone in the treatment of MCN.

Condition Nephrotic Syndrome, Nephrotic Syndrome, Lipoid nephrosis, minimal change disease
Treatment Prednisolone, Alfacalcidol
Clinical Study IdentifierNCT03210688
SponsorUniversity of Aarhus
Last Modified on4 April 2021


Yes No Not Sure

Inclusion Criteria

Biopsy proven minimal change nephropathy
If earlier minimal change: No relapse in 5 years, and earlier only treated with prednisolone
Nephrotic syndrome
Age more than 18 years

Exclusion Criteria

Cancer except from basal cells carcinoma
Lymphoproliferative disease
eGFR < 30 ml/min/1,73m2 (CKD-EPI)
No danish language
No ability to give informed prove
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note